Novel research highlights this benefit of targeting endothelin-BR receptor using {anti-ETBR immunoglobulins. Such proteins offer a specific method to affect disease functions driven by overactive ETBR signaling. https://dedn6526a-adc-parent-ant871272.wikipublicity.com/user